In our opinion, Ki-67 LI is an important prognostic factor for grade II gliomas, hut it cannot be used as a diagnostic measure alone. It must be used in combination with the other prognostic factors
Background: CNS neoplasms are a heterogenous group contributing to <2% of all the malignant neopl...
Abstract Introduction: Studies have shown that the Ki-67 index is a valuable biomarker for the diag...
The growth of tumors is highly variable and this probably reflects even its clinical course. The mon...
Background: Astrocytomas form the largest group of gliomas (>75%) and diffusely infiltrating a...
Background: Ki-67 proliferation index is widely used for differentiating between high and low-grade ...
Objective: To apply immunohistochemical marker Ki-67 and to check it’s expression in various types...
59th Annual Meeting of the American-Society-for-Therapeutic-Radiation-Oncology (ASTRO) -- SEP 24-27,...
Düşük dereceli gliomlar, daha yüksek dereceli bir tümöre dönüşme olasılığı olduğu bilinen heterojen ...
PurposeThe Ki-67/MIB-1 labeling index (LI) is clinically used to differentiate between high and low-...
Aim: To investigate survival results of patients with low grade gliomas (LGGs) and to evaluate the p...
Ki-67 expression is strongly correlated with tumour cell proliferation and growth. It is widely used...
To evaluate the accuracy of the Ki-67 labeling index (LI) as an index of brain tumor proliferation, ...
Background: Gliomas are grouped into grades 1 to 4 on the basis of morphologic criteria. Grade is th...
Background. A significant problem of brain tumors diagnostics is the subjective histological criteri...
AbstractPurposeSeizures are the most common initial symptom in patients with low-grade gliomas, and ...
Background: CNS neoplasms are a heterogenous group contributing to <2% of all the malignant neopl...
Abstract Introduction: Studies have shown that the Ki-67 index is a valuable biomarker for the diag...
The growth of tumors is highly variable and this probably reflects even its clinical course. The mon...
Background: Astrocytomas form the largest group of gliomas (>75%) and diffusely infiltrating a...
Background: Ki-67 proliferation index is widely used for differentiating between high and low-grade ...
Objective: To apply immunohistochemical marker Ki-67 and to check it’s expression in various types...
59th Annual Meeting of the American-Society-for-Therapeutic-Radiation-Oncology (ASTRO) -- SEP 24-27,...
Düşük dereceli gliomlar, daha yüksek dereceli bir tümöre dönüşme olasılığı olduğu bilinen heterojen ...
PurposeThe Ki-67/MIB-1 labeling index (LI) is clinically used to differentiate between high and low-...
Aim: To investigate survival results of patients with low grade gliomas (LGGs) and to evaluate the p...
Ki-67 expression is strongly correlated with tumour cell proliferation and growth. It is widely used...
To evaluate the accuracy of the Ki-67 labeling index (LI) as an index of brain tumor proliferation, ...
Background: Gliomas are grouped into grades 1 to 4 on the basis of morphologic criteria. Grade is th...
Background. A significant problem of brain tumors diagnostics is the subjective histological criteri...
AbstractPurposeSeizures are the most common initial symptom in patients with low-grade gliomas, and ...
Background: CNS neoplasms are a heterogenous group contributing to <2% of all the malignant neopl...
Abstract Introduction: Studies have shown that the Ki-67 index is a valuable biomarker for the diag...
The growth of tumors is highly variable and this probably reflects even its clinical course. The mon...